亚辉龙回应证监会问询函：脑机接口合作方规模较小、成立时间短

Core Viewpoint - Recently, the company announced that it received an inquiry letter from the Shanghai Stock Exchange regarding its strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd. The inquiry requires the company to disclose additional information about the main technical routes, product types, and application areas of Brain Machine Starlink, as well as analyze the synergy and feasibility of market promotion between the two parties [1][2]. Group 1 - The inquiry letter requests the company to explain the reasons for a decline in operating income and net profit by 7.69% and 72% year-on-year, respectively, for the first three quarters of 2025, and to assess the impact on its main business [1]. - The company clarified that Brain Machine Starlink is relatively small and newly established, with ongoing research products in the sleep field, including EEG acquisition and analysis instruments, brain-machine interface sleep aids, sleep monitors, and vagus nerve stimulators, none of which have entered the registration application stage [1][2]. - The vagus nerve stimulator is currently in the preparation stage for Class II medical device registration inspection, while products related to Alzheimer's disease, autism, and stroke diagnosis are still in early development or preclinical research stages [1]. Group 2 - The company emphasized that Brain Machine Starlink employs a non-invasive technology path, fundamentally differing from invasive technologies like Neuralink, and has not yet ventured into invasive technology [2]. - The current agreement is merely a strategic cooperation intention framework, with no substantial cooperation content yet, and future collaboration will depend on actual business contracts, indicating uncertainty in product development, commercialization, and agreement execution [2].